N
Description
Norwegian drug and target discovery company founded in 2009, spun out from the Centre of Excellence at Oslo University Hospital. NextCore platform for precision drug candidates through phage display, T-cell receptor (TCR) engineering and MHC class II molecules. Areas: autoimmunity, chronic inflammation and cancer. Collaborates with J&J Innovation and Karolinska Institutet.